Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoimmunology.

Martina Rauner1, Wolfgang Sipos, Peter Pietschmann

  • 1Ludwig Boltzmann Institute of Aging Research, Vienna, Austria.

International Archives of Allergy and Immunology
|December 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum: [Corrigendum] Imatinib mesylate and nilotinib decrease synthesis of bone matrix <i>in vitro</i>.

Oncology letters·2026
Same author

Effect of the JAK Inhibitor Baricitinib on Cytokine Production and Bone Properties in a Mouse Model of Accelerated Aging.

International journal of molecular sciences·2026
Same author

[Diagnosis and management of diabetes and co-existing osteoporosis (Update 2026)].

Wiener klinische Wochenschrift·2026
Same author

Increased fracture risk associated with iron-deficiency anemia: a population-based propensity score matched cohort study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same author

Effect of alendronate on survival and bone properties in Nothobranchius furzeri: insights from a model of accelerated aging.

Experimental gerontology·2026
Same author

Preclinical efficacy of tasquinimod in myelodysplastic neoplasms: Restoring erythropoiesis and mitigating bone loss.

HemaSphere·2026
Same journal

Effectiveness of a Provincial Law to Improve Epinephrine Use for Anaphylaxis in Schools in Alberta, Canada: A Pre-Post Study.

International archives of allergy and immunology·2026
Same journal

Rab27 a regulates dendritic cell immune tolerogenic capacity.

International archives of allergy and immunology·2026
Same journal

Burden of Hereditary Angioedema in Adults: Impact of Disease and Patient Characteristics.

International archives of allergy and immunology·2026
Same journal

Predictors of Treatment Response to Omalizumab in Children with Chronic Spontaneous Urticaria: A Real World Study.

International archives of allergy and immunology·2026
Same journal

Long-term efficacy beyond 10 years of subcutaneous immunotherapy for house-dust-mite-induced allergic rhinitis: A real-world evidence study.

International archives of allergy and immunology·2026
Same journal

Clinical Characteristics and Severity of Pediatric Anaphylaxis in the Emergency Department: A Six-Year Study Based on WAO Criteria.

International archives of allergy and immunology·2026
See all related articles

Osteoimmunology explores the link between bone health and the immune system. Understanding these connections, like the role of RANKL in bone loss, can lead to new treatments for inflammatory diseases and osteoporosis.

Area of Science:

  • Interdisciplinary research at the intersection of osteology and immunology.

Background:

  • Inflammatory diseases, such as rheumatoid arthritis, are linked to accelerated bone loss.
  • Receptor activator of nuclear factor kappaB ligand (RANKL) drives osteoclastogenesis and bone resorption.
  • Osteoporosis and other conditions show associations with immune system alterations.

Purpose of the Study:

  • To introduce bone remodeling and its cellular regulators.
  • To summarize recent discoveries in osteoimmunology.
  • To highlight immune system's role in osteoporosis and discuss alternative animal models.

Main Methods:

  • Review of existing literature on osteoimmunology.
  • Analysis of the role of RANKL in inflammatory bone loss.
  • Investigation of immune cell and osteoblast/osteoclast interactions.

Related Experiment Videos

Main Results:

  • Activated T cells increase RANKL expression, promoting osteoclast activity and bone loss.
  • Osteoblasts are crucial for hematopoietic stem cell niches and lymphocyte development.
  • Shared molecular pathways (cytokines, transcription factors) exist between skeletal and immune systems.

Conclusions:

  • Osteoimmunology offers insights into bone loss mechanisms in various diseases.
  • Understanding immune-skeletal crosstalk can reveal novel therapeutic targets.
  • Further research in osteoimmunology promises innovative treatments for bone disorders.